Cargando…
Cost-effectiveness of smoking cessation to prevent age-related macular degeneration
BACKGROUND: Tobacco smoking is a risk factor for age-related macular degeneration, but studies of ex-smokers suggest quitting can reduce the risk. METHODS: We fitted a function predicting the decline in risk of macular degeneration after quitting to data from 7 studies involving 1,488 patients. We a...
Autores principales: | Hurley, Susan F, Matthews, Jane P, Guymer, Robyn H |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2562365/ https://www.ncbi.nlm.nih.gov/pubmed/18783631 http://dx.doi.org/10.1186/1478-7547-6-18 |
Ejemplares similares
-
Cost-effectiveness of ranibizumab for neovascular age-related macular degeneration
por: Hurley, Susan F, et al.
Publicado: (2008) -
Biomarkers for the Progression of Intermediate Age-Related Macular Degeneration
por: Lad, Eleonora M., et al.
Publicado: (2023) -
Comparison of Visual Function Tests in Intermediate Age-Related Macular Degeneration
por: Guymer, Robyn H., et al.
Publicado: (2021) -
Subthreshold Nano-Second Laser Treatment and Age-Related Macular Degeneration
por: Cohn, Amy C., et al.
Publicado: (2021) -
Role of sleep-disordered breathing in age-related macular degeneration
por: Fang, Wendy Ying, et al.
Publicado: (2023)